Complix
14 known investors
Find your way into Complix
Sign up to see every warm intro you have to Complix
- Paths you didn't know you had: your email and LinkedIn already hold routes to the Complix team. We find them for you
- 2nd- and 3rd-degree connections: the friend-of-a-friend routes that take hours to manually find through your inbox or LinkedIn
- Answers now, not in days: momentum is everything in a raise. Skip asking around whether someone knows someone
Days of research, done the moment you sign in, with every route ranked by how warm it is.
Complix develops therapeutic biologics based on Alphabody technology targeting viral diseases, oncology, and autoimmune conditions. The company focuses on cell-penetrating therapeutics designed to reach intracellular disease targets.
Investors · 14
How we know: Andera Partners's portfolio page · Not right? Tell us
How we know: open dataset · 5k.vc investor directory · Not right? Tell us
How we know: funding news · prnewswire.com · Not right? Tell us
How we know: funding news · prnewswire.com · Not right? Tell us
Also in the syndicate · 9
Funding
SEC filings, press & company announcements- Undisclosed amountSeries BJun 2013
Biotech Fund Flanders (lead), Edmond de Rothschild Investment Partners (lead), Gimv (lead), Baekeland Fund, CRP-Santé, Gemma Frisius Fund, LRM, OMNES Capital, TrustCapital, Vesalius Biocapital, Vinnof
Source ↗
Source: company announcements and press reports — follow each round's link for the claim.
Related companies · 1
Companies working in the same space as Complix.
In the news
Frequently asked questions
- What does Complix do?
- Complix develops therapeutic biologics based on Alphabody technology targeting viral diseases, oncology, and autoimmune conditions. The company focuses on cell-penetrating therapeutics designed to reach intracellular disease targets.
- Who are Complix's investors?
- Complix's investors include PMV, Andera Partners, Vesalius Biocapital Partners, Gimv, Omnes Capital.



